Clicky

Green Cross(005250)

Description: Green Cross Holdings Corporation operates as a biotechnology company. The company provides plasma derivatives, prescription drugs, over the counter drugs, and hunter syndrome drugs; and vaccines for hemorrhagic fever, varicella, hepatitis-B, and flu. It also researches and develops oncology, immunology, and cell therapy products; and offers recombinant protein treatment for hemophilia. The company has partnerships and collaborations with biotech companies and academia for development of new drugs and technologies. Green Cross Holdings was founded in 1967 and is headquartered in Yongin, South Korea.


Keywords: Biotechnology Life Sciences Biology Vaccines Cell Therapy Hemophilia Cell Therapy Products Recombinant Dna Varicella Green Cross Hunter Syndrome Hemorrhagic Fever Treatment For Hemophilia

Home Page: www.greencross.com

107, Ihyeon-ro 30beon-gil
Yongin-Si,
South Korea
Phone: 82 3 1260 9300


Officers

Name Title
Mr. Il-Sup Huh Ph.D. Chairperson and Chief Exec. Officer
Dr. Eun Chul Huh Pres
Mr. Yong-jun Hur VP & Director
Mr. Man-Goo Yoo Managing Director
Ms. Ae-Kyung Jang Managing Director
Mr. Pyung-Ju Jang Sr. Managing Director
Mr. Yong-Jun Huh VP and Director

Exchange: KO

Country: KR

Currency: Korean Won (₩)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.8228
Price-to-Sales TTM: 0.399
IPO Date:
Fiscal Year End: December
Full Time Employees: 160
Back to stocks